Supplementary Methods from A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with BRAF-Mutant Cancers Using Pharmacokinetics-Informed Dose Escalation
Authors:
- Rona YaegerRYRona Yaeger
- Meredith A. McKeanMMMeredith A. McKean
- Rizwan HaqRHRizwan Haq
- J. Thaddeus BeckJBJ. Thaddeus Beck
- Matthew H. TaylorMTMatthew H. Taylor
- Jonathan E. CohenJCJonathan E. Cohen
- Daniel W. BowlesDBDaniel W. Bowles
- Shirish M. GadgeelSGShirish M. Gadgeel
- Catalin MihalcioiuCMCatalin Mihalcioiu
- Kyriakos P. PapadopoulosKPKyriakos P. Papadopoulos
- Eli L. DiamondEDEli L. Diamond
- Keren B. SturtzKSKeren B. Sturtz
Open Access
- 17 June 2026
- other
- Published by American Association for Cancer Research (AACR)